Name
Session 4: Therapeutic Innovation
Date & Time
Saturday, September 19, 2026, 1:30 PM - 3:05 PM
Speakers
Amine Benmassaoud, McGill University
Marc Bilodeau, Université de Montréal
Vanessa Tardio, Endocrinology McGill
Alnoor Ramji, UBC
James Kim, University of Calgary
George Thanassoulis, Cardiology
Mark Swain, Calgary
Marc Bilodeau, Université de Montréal
Vanessa Tardio, Endocrinology McGill
Alnoor Ramji, UBC
James Kim, University of Calgary
George Thanassoulis, Cardiology
Mark Swain, Calgary
Description
The MASH Moment: Therapeutics and the Future of SLD Care
Moderated by Marc Bilodeau and Amine Benmassaoud
Featuring
- Metabolic Management: The Endocrinology Perspective on SLD with Vanessa Tardio
- Pathways for management Hepatology with Alnoor Ramji
- Frontline SLD Care: The Role of Primary Care with James Kim
- Cardiovascular risk assessment in patients with MASLD with George Thanassoulis
- What’s Coming Next? Inside the MASH Pipeline with Mark Swain
- Q&A /Panel: Who Should Be Treated—and by Who? with all speakers